Alba Mota

736 total citations
13 papers, 364 citations indexed

About

Alba Mota is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Alba Mota has authored 13 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Reproductive Medicine. Recurrent topics in Alba Mota's work include Ovarian cancer diagnosis and treatment (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Cancer Genomics and Diagnostics (3 papers). Alba Mota is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Cancer Genomics and Diagnostics (3 papers). Alba Mota collaborates with scholars based in Spain, United States and Brazil. Alba Mota's co-authors include Gema Moreno‐Bueno, Pablo García‐Sanz, Alejandro Rojo‐Sebastián, Marta Hergueta‐Redondo, Ángela Molina-Crespo, Saleta Morales, Héctor Peinado, Diego Megı́as, Amparo Cano and David Sarrió and has published in prestigious journals such as PLoS ONE, The FASEB Journal and International Journal of Cancer.

In The Last Decade

Alba Mota

12 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alba Mota Spain 9 226 104 70 65 52 13 364
Antonia Wenners Germany 11 101 0.4× 74 0.7× 51 0.7× 35 0.5× 102 2.0× 21 306
Brian C. Willis United States 7 79 0.3× 52 0.5× 54 0.8× 48 0.7× 162 3.1× 9 305
Luisa Valvassori Italy 9 187 0.8× 68 0.7× 143 2.0× 56 0.9× 112 2.2× 9 424
Victor Ng United States 9 158 0.7× 65 0.6× 61 0.9× 45 0.7× 82 1.6× 17 393
Masataka Takenaka Japan 9 133 0.6× 54 0.5× 23 0.3× 41 0.6× 96 1.8× 22 342
Deyu Zhang China 12 164 0.7× 101 1.0× 34 0.5× 131 2.0× 90 1.7× 34 424
Shiro Takamatsu Japan 8 134 0.6× 78 0.8× 139 2.0× 55 0.8× 273 5.3× 26 413
Nathalie L.G. Sieben Netherlands 8 195 0.9× 131 1.3× 41 0.6× 50 0.8× 108 2.1× 8 433
Shengwei Mo China 11 93 0.4× 56 0.5× 157 2.2× 50 0.8× 217 4.2× 30 348
Sho Sato Japan 12 117 0.5× 81 0.8× 101 1.4× 67 1.0× 157 3.0× 32 411

Countries citing papers authored by Alba Mota

Since Specialization
Citations

This map shows the geographic impact of Alba Mota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alba Mota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alba Mota more than expected).

Fields of papers citing papers by Alba Mota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alba Mota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alba Mota. The network helps show where Alba Mota may publish in the future.

Co-authorship network of co-authors of Alba Mota

This figure shows the co-authorship network connecting the top 25 collaborators of Alba Mota. A scholar is included among the top collaborators of Alba Mota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alba Mota. Alba Mota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mota, Alba, Sara S. Oltra, & Gema Moreno‐Bueno. (2020). Insight updating of the molecular hallmarks in ovarian carcinoma. European Journal of Cancer Supplements. 15. 16–26. 13 indexed citations
2.
Mota, Alba, Alejandro Rojo‐Sebastián, Ángela Rynne‐Vidal, et al.. (2019). Prostaglandin F2α-induced Prostate Transmembrane Protein, Androgen Induced 1 mediates ovarian cancer progression increasing epithelial plasticity. Neoplasia. 21(11). 1073–1084. 7 indexed citations
3.
Santacana, Marı́a, Pluvio Coronado, Xavier Matías‐Guiu, et al.. (2016). Biological Effects of Temsirolimus on the mTOR Pathway in Endometrial Carcinoma. International Journal of Gynecological Cancer. 1–1. 3 indexed citations
4.
Piscuoglio, Salvatore, Felipe C. Geyer, Kathleen A. Burke, et al.. (2016). Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor. npj Breast Cancer. 2(1). 16035–16035. 34 indexed citations
5.
Mota, Alba, Eva Colás, Pablo García‐Sanz, et al.. (2016). Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers. Modern Pathology. 30(1). 134–145. 33 indexed citations
6.
García‐Sanz, Pablo, Juan Carlos Triviño, Alba Mota, et al.. (2016). Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma. International Journal of Cancer. 140(7). 1551–1563. 30 indexed citations
7.
Romero‐Pérez, Laura, Pablo García‐Sanz, Alba Mota, et al.. (2015). A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer. Modern Pathology. 28(11). 1492–1503. 23 indexed citations
8.
Mota, Alba, Juan Carlos Triviño, Alejandro Rojo‐Sebastián, et al.. (2015). Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression. BMC Cancer. 15(1). 940–940. 17 indexed citations
9.
Mota, Alba, et al.. (2015). α-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation. Toxicology and Applied Pharmacology. 286(3). 168–177. 7 indexed citations
10.
Santacana, Marı́a, Óscar Maiques, Joan Valls, et al.. (2014). A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry. Human Pathology. 45(12). 2394–2403. 17 indexed citations
11.
Hergueta‐Redondo, Marta, David Sarrió, Ángela Molina-Crespo, et al.. (2014). Gasdermin-B Promotes Invasion and Metastasis in Breast Cancer Cells. PLoS ONE. 9(3). e90099–e90099. 154 indexed citations
12.
Gonzalo, Pilar, Alba Mota, Ángela Pollán, et al.. (2012). The protease MT1‐MMP drives a combinatorial proteolytic program in activated endothelial cells. The FASEB Journal. 26(11). 4481–4494. 26 indexed citations
13.
Vilas‐Boas, Fábio, et al.. (2007). Bone marrow cell transplantation to the myocardium is safe and potentially effective in patients with heart failure due to Chagas' cardiomyopathy. Cardiovascular revascularization medicine. 8(2). 122–123.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonia Wenners Breakdown of academic impact, for papers by Brian C. Willis Breakdown of academic impact, for papers by Luisa Valvassori Breakdown of academic impact, for papers by Victor Ng Breakdown of academic impact, for papers by Masataka Takenaka Breakdown of academic impact, for papers by Deyu Zhang Breakdown of academic impact, for papers by Shiro Takamatsu Breakdown of academic impact, for papers by Nathalie L.G. Sieben Breakdown of academic impact, for papers by Shengwei Mo Breakdown of academic impact, for papers by Sho Sato
Rankless by CCL
2026